
浏览全部资源
扫码关注微信
1.400038 重庆,陆军军医大学(第三军医大学):第一附属医院消化内科
2.400038 重庆,陆军军医大学(第三军医大学):军事预防医学系复合伤研究所
[陈文生,E-mail:wenshengchen@hotmail.comCHEN Wensheng, E-mail: wenshengchen@hotmail.com
收稿:2023-07-25,
修回:2023-08-25,
纸质出版:2023-10-15
移动端阅览
吴天宇, 宋娅岚, 吴静峰, 等. 腺相关病毒过表达IL22可有效改善葡聚糖硫酸钠诱导的小鼠结肠炎[J]. 陆军军医大学学报, 2023,45(19):1995-2006.
Tianyu WU, Yalan SONG, Jingfeng WU, et al. Overexpression of IL22 by adeno-associated virus effectively ameliorates dextran sulfate sodium-induced colitis in mice[J]. Journal of Army Medical University, 2023, 45(19): 1995-2006.
吴天宇, 宋娅岚, 吴静峰, 等. 腺相关病毒过表达IL22可有效改善葡聚糖硫酸钠诱导的小鼠结肠炎[J]. 陆军军医大学学报, 2023,45(19):1995-2006. DOI: 10.16016/j.2097-0927.202307121.
Tianyu WU, Yalan SONG, Jingfeng WU, et al. Overexpression of IL22 by adeno-associated virus effectively ameliorates dextran sulfate sodium-induced colitis in mice[J]. Journal of Army Medical University, 2023, 45(19): 1995-2006. DOI: 10.16016/j.2097-0927.202307121.
目的
2
探讨白介素22(IL22)在小鼠葡聚糖硫酸钠(dextran sulfate sodium salt
DSS)诱导的急性结肠炎中的作用及其机制。
方法
2
选取8周龄雄性同窝IL22敲除小鼠(IL22
-/-
)及对照基因型小鼠(IL22
+/+
)各3只
给予2组小鼠2.5%DSS自由饮水6 d、正常饮水2 d构建小鼠急性结肠炎模型,记录小鼠体质量变化及疾病活动指数(disease activity index,DAI),干预8 d后行小鼠肠道内窥镜检查,测量2组小鼠结肠长度以及主要免疫器官脏器指数,采用Western blot检测白介素1α(IL1α)、白介素1β(IL1β)、白介素6(IL6)、肿瘤坏死因子α(TNFα)等促炎细胞因子蛋白水平表达;选取8周龄雄性C57BL/6小鼠建立腺相关病毒(adeno-associated virus,AAV)转染模型,给予DSS诱导结肠炎模型,设置PBS组(
n
=5)、AAV-mock+DSS组(
n
=5)、AAV-IL22+DSS组(
n
=5),采用免疫荧光检测各组结肠闭合小环蛋白1(ZO-1)、钙粘附蛋白(E-claudin)表达,采用Western blot检测IL22、闭合蛋白(Occludin)、信号传导及转录激活蛋白3(Stat3)、p-Stat3蛋白表达水平。
结果
2
与IL22
+/+
组比较,IL22
-/-
组小鼠在DSS诱导后第8天体质量显著降低(
P
<0.05),DAI评分(
P
<0.01)和肠镜评分显著升高(
P
<0.05),组织损伤加重,病理评分显著升高(
P
<0.01),促炎细胞因子IL1α、IL1β、cleaved-IL1β、IL6、TNFα表达上调(
P
<0.05)。与AAV-mock+DSS组相比,AAV-IL22+DSS组可逆转DSS诱导结肠炎,结肠组织炎症水平显著降低(
P
<0.05),免疫荧光结果示E-claudin表达显著升高(
P
<0.05),Western blot结果显示Occludin、p-Stat3表达水平显著增高(
P
<0.01)。
结论
2
IL22缺乏加重小鼠DSS诱导结肠炎,而通过AAV过表达IL22能增强结肠紧密连接蛋白表达,减少炎症浸润,缓解DSS肠炎,其机制可能与Jak/Stat3通路激活有关。
Objective
2
To investigate the effects of interleukin22 (IL22) in acute colitis induced by dextran sulfate sodium salt (DSS) in mice and its underlying mechanism.
Methods
2
Three IL22 knockout mice (IL22
-/-
) and 3 control mice (IL22
+/+
) of 8-week-old males were subjected from the same litter
and then had free-choice drinking of 2.5% DSS water for 6 d followed by normal water for 2 d to construct a mouse model of acute colitis. The changes in body mass weight and disease activity index (DAI) were measured and calculated. After the intervention of 8 d
mouse enteroscopy was performed
and the length of colon and the organ index of major immune organs were measured in both groups. Protein levels of pro-inflammatory cytokines
such as IL1α
IL1β
IL6 and TNFα were detected by Western blotting. Adeno-associated virus (AAV) transfection model was established in 8-week-old male C57BL/6 mice
which were then treated by 2.5%DSS drinking. The mice were randomly divided into PBS group (
n
=5)
AAV-mock+DSS group (
n
=5) and AAV-IL22+DSS group (
n
=5). The expression levels of colonic closed small loop protein 1 (ZO-1) and calcium adhesion protein (E-claudin) in different groups were detected by immunofluorescence assay. The protein levels of IL22
Occludin
Stat3 and p-Stat3 were detected by Western blotting.
Results
2
Compared with the IL22
+/+
group
the mice in the IL22
-/-
group had significantly decreased body weight on day 8 (
P
<
0.05)
obviously increased DAI score (
P
<
0.01)
endoscopy score (
P
<
0.05) and pathological score (
P
<
0.01) after DSS induction
and notable up-regulation of pro-infla
mmatory cytokines including IL1α
IL1β
cleaved-IL1β
IL6
and TNFα in the colon tissues (
P
<
0.05). While AAV-IL22 transfection reversed DSS-induced colitis. Significantly reduced inflammation in colonic tissues (
P
<
0.05)
enhanced E-claudin expression (
P
<
0.05) and up-regulation of p-Stat3 and Occludin (
P
<
0.01) were observed in the AAV-IL22+DSS group than the AAV-mock+DSS group.
Conclusion
2
IL22 deficiency aggravates DSS-induced colitis in mice
and its overexpression by AAV-IL22 alleviates DSS enteritis by enhancing colonic tight junction proteins and reducing inflammatory infiltration
which may be related to the activation of Jak/Stat3 pathway.
KAPLAN G G. The global burden of IBD: from 2015 to 2025[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(12): 720-727. DOI: 10.1038/nrgastro.2015.150.
PARIGI T L, D'AMICO F, ABREU M T, et al . Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting[J ] . Lancet Gastroenterol Hepatol, 2023, 8(9): 853-859. DOI: 10.1016/S2468-1253(23)00154-1.
PIOVANI D, DANESE S, PEYRIN-BIROULET L, et al . Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses[J ] . Gastroenterology, 2019, 157(3): 647-659. e4. DOI: 10.1053/j.gastro.2019.04.016.
FAYE A S, COLOMBEL J F. Aging and IBD: a new challenge for clinicians and researchers[J]. Inflamm Bowel Dis, 2022, 28(1): 126-132. DOI: 10.1093/ibd/izab039.
ORDÁS I, ECKMANN L, TALAMINI M, et al . Ulcerative colitis[J ] . Lancet, 2012, 380(9853): 1606-1619. DOI: 10.1016/s0140-6736(12)60150-0.
KEIR M, YI T S, LU T, et al . The role of IL-22 in intestinal health and disease[J ] . J Exp Med, 2020, 217(3): e20192195. DOI: 10.1084/jem.20192195.
SABAT R, OUYANG W, WOLK K. Therapeutic opportunities of the IL-22-IL-22R1 system[J]. Nat Rev Drug Discov, 2014, 13(1): 21-38. DOI: 10.1038/nrd4176.
NAMBU R, WARNER N, MULDER D J, et al . A systematic review of monogenic inflammatory bowel disease[J ] . Clin Gastroenterol Hepatol, 2022, 20(4): e653-e663. DOI: 10.1016/j.cgh.2021.03.021.
KIM S, HONG E H, LEE C K, et al . Amelioration of DSS-induced acute colitis in mice by recombinant monomeric human interleukin-22[J ] . Immune Netw, 2022, 22(3): e26. DOI: 10.4110/in.2022.22.e26.
HSUEH Y H, CHANG Y N, LOH C E, et al . AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis[J ] . J Autoimmun, 2016, 66: 89-97. DOI: 10.1016/j.jaut.2015.10.005.
PUPO A, FERNÁNDEZ A, LOW S H, et al . AAV vectors: the Rubik's cube of human gene therapy[J ] . Mol Ther, 2022, 30(12): 3515-3541. DOI: 10.1016/j.ymthe.2022.09.015.
KUZMIN D A, SHUTOVA M V, JOHNSTON N R, et al . The clinical landscape for AAV gene therapies[J ] . Nat Rev Drug Discov, 2021, 20(3): 173-174. DOI: 10.1038/d41573-021-00017-7..
BEZZIO C, DELLA CORTE C, VERNERO M, et al . Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations[J ] . Therap Adv Gastroenterol, 2022, 15: 17562848221115312. DOI: 10.1177/17562848221115312.
JIANG P, ZHENG C, XIANG Y, et al . The involvement of TH17 cells in the pathogenesis of IBD[J ] . Cytokine Growth Factor Rev, 2023, 69: 28-42. DOI: 10.1016/j.cytogfr.2022.07.005.
PELCZAR P, WITKOWSKI M, PEREZ L G, et al . A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease[J ] . Science, 2016, 354(6310): 358-362. DOI: 10.1126/science.aah5903.
ROTHENBERG M E, WANG Y H, LEKKERKERKER A, et al . Randomized phase Ⅰ healthy volunteer study of UTTR1147A (IL-22Fc): a potential therapy for epithelial injury[J ] . Clin Pharmacol Ther, 2019, 105(1): 177-189. DOI: 10.1002/cpt.1164.
LAURENCE A, SHEA J J, WATFORD W T. Interleukin-22: a sheep in wolf's clothing[J]. Nat Med, 2008, 14(3): 247-249. DOI: 10.1038/nm0308-247.
SEIDERER J,BRAND S. IL-22: a two-headed cytokine in IBD?[J]. Inflamm Bowel Dis, 2009, 15(3): 473-474. DOI: 10.1002/ibd.20625.
HEBERT K D, MCLAUGHLIN N, GALEAS-PENA M, et al . Targeting the IL-22/IL-22BP axis enhan ces tight junctions and reduces inflammation during influenza infection[J ] . Mucosal Immunol, 2020, 13(1): 64-74. DOI: 10.1038/s41385-019-0206-9.
ZHAO Y X, LUAN H F, JIANG H, et al . Gegen Qinlian Decoction relieved DSS-induced ulcerative colitis in mice by modulating Th17/Treg cell homeostasis via suppressing IL-6/JAK2/STAT3 signaling[J ] . Phytomedicine, 2021, 84: 153519. DOI: 10.1016/j.phymed.2021.153519..
KAYAMA H, OKUMURA R, TAKEDA K. Interaction between the microbiota, epithelia, and immune cells in the intestine[J]. Annu Rev Immunol, 2020, 38: 23-48. DOI: 10.1146/annurev-immunol-070119-115104.
ZWARYCZ B, GRACZ A D, RIVERA K R, et al . IL22 inhibits epithelial stem cell expansion in an ileal organoid model[J ] . Cell Mol Gastroenterol Hepatol, 2019, 7(1): 1-17. DOI: 10.1016/j.jcmgh.2018.06.008.
BEVINS C L, SALZMAN N H. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis[J]. Nat Rev Microbiol, 2011, 9(5): 356-368. DOI: 10.1038/nrmicro2546.
SERAFINI N, JARADE A, SURACE L, et al . Trained ILC3 responses promote intestinal defen se[J ] . Science, 2022, 375(6583): 859-863. DOI: 10.1126/science.aaz8777.
GU P Y, WANG D D, ZHANG J, et al . Protective function of interleukin-22 in pulmonary fibrosis[J ] . Clin Transl Med, 2021, 11(8): e509. DOI: 10.1002/ctm2.509.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621